Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Neuroendocrine Carcinoma of the Skin”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04291885
What this trial is testing

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage II+3 more
Melanoma and Skin Cancer Trials Limited 122
Testing effectiveness (Phase 2)Study completedNCT01134250
What this trial is testing

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Who this might be right for
Solid TumorBreast CancerMetastatic Melanoma+1 more
Philogen S.p.A. 48
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Testing effectiveness (Phase 2)Study completedNCT02404441
What this trial is testing

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Sell Lung Cancer (NSCLC)Triple Negative Breast Cancer+2 more
Novartis Pharmaceuticals 319
Testing effectiveness (Phase 2)Study completedNCT00070642
What this trial is testing

CPG 7909 Injection in Melanoma

Who this might be right for
Carcinoma, Melanoma
Pfizer 184
Testing effectiveness (Phase 2)Study completedNCT00462982
What this trial is testing

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer
Memorial Sloan Kettering Cancer Center 8
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Testing effectiveness (Phase 2)Study completedNCT01013779
What this trial is testing

Merkel Positron Emission Tomography (PET) Protocol

Who this might be right for
Merkel Cell Carcinoma
Trans Tasman Radiation Oncology Group 43
Testing effectiveness (Phase 2)Looking for participantsNCT06814496
What this trial is testing

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Who this might be right for
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
University of Arizona 30
Early research (Phase 1)Active Not RecruitingNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Testing effectiveness (Phase 2)Study completedNCT00003549
What this trial is testing

S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

Who this might be right for
Neuroendocrine Carcinoma of the Skin
SWOG Cancer Research Network 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Testing effectiveness (Phase 2)Looking for participantsNCT07115043
What this trial is testing

Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more
AstraZeneca 60
Testing effectiveness (Phase 2)Temporarily pausedNCT00033956
What this trial is testing

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Who this might be right for
IL-2 Induced Hypotension
MetaPhore Pharmaceuticals 48
Early research (Phase 1)Active Not RecruitingNCT04975152
What this trial is testing

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 36
Load More Results